SEC reporting owner

Carvajal Alejandra SEC insider disclosures

Explore Carvajal Alejandra's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001645755
Issuers
3
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Cerulean Pharma Inc.0001401914CERUYesNo
MOMENTA PHARMACEUTICALS INC0001235010MNTAYesNo
Mersana Therapeutics, Inc.0001442836MRSNYesNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-08-062026-08-03CTMXA100,000Not reported
2026-08-062026-08-03CTMXA450,000Not reported
2025-01-182025-01-16MRSNS5,096Not reported
2025-01-182025-01-15MRSNA54,167Not reported
2025-01-182025-01-15MRSNA243,750Not reported
2025-01-172025-01-15MRSNS952Not reported
2025-01-162025-01-14MRSNS3,330Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.